Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006) [Phase 3]

View source ↗

Summary

This Phase 3 study evaluates tezepelumab in adults with moderate to very severe COPD. Recruitment is ongoing and results are not yet available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tezspire (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: RECRUITING